Follow Us
https://www.thebody.com/category/hiv-drugs-development
HIV Treatment and Medical Care

HIV Drugs In Development

The Latest

Q&A: Ask the Experts

chosing the best available regimen

I ALWAYS like to be on the best latest regimen.,,, ( lucky to have insurance that pays ok) Doing well on triumeq... ( <20 cd4 780 37%, stable for many years) Started d4t/zerit/viracept in 1995? made changes as times changed, .. atripla. stribild, tiv...

What Is an Investigational HIV Drug? Img

What Is an Investigational HIV Drug?

This fact sheet explains what investigational HIV drugs are, how trials are conducted, and how access can be obtained through clinical trials and expanded access programs.

HIV/AIDS Clinical Trials Img

HIV/AIDS Clinical Trials

Key PointsHIV/AIDS clinical trials are research studies that look at new ways to prevent, detect, or treat HIV/AIDS. Clinical trials are the fastest way to determine if new medical approaches to HIV/AIDS are safe and effective in people.Examples of...

Q&A: Ask the Experts

I want to take ART once a year

Hi doctor. My CD4 count is 784,viral load is 1286 and I don't want to take ARVs I only want that one we take yearly as am afraid I will forget to take them sometimes as am always busy at work

What Is a Therapeutic HIV Vaccine? Img

What Is a Therapeutic HIV Vaccine?

Unlike a preventive HIV vaccine, a therapeutic HIV vaccine is designed to improve the body's immune response to HIV in people who are already infected with the virus. In the future, these vaccines could eliminate HIV from the body, or improve the bod...

PrEP Trials: The Benefits -- and Challenges -- of Seeking Community Input Img
News

PrEP Trials: The Benefits -- and Challenges -- of Seeking Community Input

Last fall, community activists voiced concerns over the roll out of studies on Descovy (TAF/FTC) as pre-exposure prophylaxis (PrEP) without adequately involving community advisors.

Joseph Eron, Jr., M.D., presents 96-week study data from LATTE-2, at IAS 2017 (Credit: Warren Tong)
News

Long-Acting Injectable HIV Treatment Moves Closer to Reality

Long-acting injectable treatment takes another step closer to being a real-world option for people living with HIV, with new study results presented at IAS 2017.

Surprise FDA Approval of Generic Truvada Is a 'Wakeup Call' for Activists Img
News

Surprise FDA Approval of Generic Truvada Is a 'Wakeup Call' for Activists

The surprise approval of generic Truvada (tenofovir disoproxil fumarate and emtricitabine) by the U.S. Food and Drug Administration (FDA) on June 9 left patients, advocates and doctors scrambling to understand exactly when the generic will become ava...

Q&A: Ask the Experts

TIB Drug

Dear Doctor, Thanks for your kind answers. I would like now to know whether you have reviewed any new information regarding TIB as an alternative to ART. Basically they say its a functional cure as its inhibits infection of the CD cells. It is said r...

Ibalizumab: First Long-Acting HIV Treatment Available Now Via Expanded Access Img
News

Ibalizumab: First Long-Acting HIV Treatment Available Now Via Expanded Access

Ibalizumab, a drug that works against multi-drug-resistant HIV, is now available via the manufacturer's expanded access program.